Slomovitz BM, Filiaci VL, Walker JL, Taub MC, et al. A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study. Gynecol Oncol 2022 Jan 18. pii: S0090-8258(21)01699.
PMID: 35063278